Clinical Trial

Hypothyroidism After the TAVI Procedure in Elderly Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Aortic stenosis is highly prevalent in advancing age. The prognosis of this disease has dramatically changed with the surgical replacement of the aortic valve and the trans catheter aortic valve re-placement (TAVI). The TAVI procedure is also successful in octogenarians and frail patients. However, the evaluation before the TAVI procedure requires a high dosage of iodinated contrast agent with, consequently, an increased risk for thyroid dysfunction. The primary endpoint of this study is to assess, prospectively, the incidence and the predictive factors (underlying thyroid disease, medication, food preservative, topical antiseptics) of hypothyroidism after a TAVI procedure. The secondary endpoint is the influence of the occurrence of hypothyroidism after the TAVI procedure on the geriatric assessment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-04-02; most recent amendment 2024-12-04.
Status change: Not Yet Recruiting → Recruiting 2021-08-05
Trial Details
NCT Number NCT04831957
Lead Sponsor Universitair Ziekenhuis Brussel
Conditions Hypothyroidism, TAVI
Enrollment 20 participants
Start Date 2021-07-26
Primary Completion 2050-12-31 (estimated)
Study Completion 2050-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-09